ANTI-ECSCR ANTIBODY AND USES THEREOF

摘要

Described are antibodies which bind ECSCR and inhibit chemotaxis. The antibodies may bind an epitope QTVPPNSTTM on the extracellular domain of ECSCR. The antibodies, which may be provided as a pharmaceutical composition, may be used to inhibit tumour cell invasion and may be used in the treatment of diseases, for example diseases associated with angiogenesis such as- cancer.